Search
(+)
cartoon
dealer
buy stock illustrations
Home
My rookie portfolio
📷 Upload yours 🤳
Find results that contain
all
of your keywords. Content filter is
on
. Search will return
best illustrations, stock vectors and clipart
.
Exclude
Make it so!
You have chosen to exclude "
" from your results.
Choose orientation:
Explore cartoons & images using related keywords:
2801
4482
anti
antiviral
background
based
capsule
care
chemistry
clinic
clinical
closeup
concept
coronavirus
covid
cure
doctor
dose
drug
eidd
emory
epidemic
formula
health
healthy
hospital
illness
infection
isolated
laboratory
medical
medicament
medication
medicine
merck
molecular
molnupiravir
nucleoside
oral
pain
pandemic
pharmaceutical
pharmacy
pill
prescription
prevention
render
tablets
treatment
trial
12.19.2021 Molnupiravir Capsules. Synthetic Nucleoside Based Covid-19 Drug. 3D Render. Editorial Image
Download
Designed by
Creuxnoir
Title
12.19.2021 Molnupiravir capsules. Synthetic nucleoside based covid-19 drug. 3D render. #237207864
Description
Medical concept 3D render drug design
This image is editorial
A hand holding a phone with the Merck pharmaceutical company app on the screen
A hand holding a phone with the Merck pharmaceutical company app on the screen
a molnupiravir by merck and ridgeback corona medication
A molnupiravir by merck and ridgeback corona medication
Kharkiv. Ukraine. November 14, 2021. The world`s first antiviral capsule Molnupiravir to fight the corona virus COVID-19.
Kharkiv. Ukraine. November 14, 2021. The world`s first antiviral capsule Molnupiravir to fight the corona virus COVID-19.
Kharkiv. Ukraine. November 14, 2021. The world`s first antiviral capsule Molnupiravir to fight the corona virus COVID-19.
Kharkiv. Ukraine. November 14, 2021. The world`s first antiviral capsule Molnupiravir to fight the corona virus COVID-19.
Kharkiv. Ukraine. November 14, 2021. The world`s first antiviral capsule Molnupiravir to fight the corona virus COVID-19.
Kharkiv. Ukraine. November 14, 2021. The world`s first antiviral capsule Molnupiravir to fight the corona virus COVID-19.
Merck and Ridgebackââ¬â¢s Molnupiravir, an Oral COVID-19 Antiviral Medicine, Receives First Authorization in the World
November 26, 2021, Brazil. In this photo illustration Merck Sharp & Dohme MSD logo is seen on a screen and a hand holding a pill
November 26, 2021, Brazil. In this photo illustration Merck Sharp & Dohme MSD logo is seen on a screen and a hand holding a pill
12.19.2021 Molnupiravir capsules. Synthetic nucleoside based covid-19 drug. 3D render.